Abstract:The normal ageing process affects resistance arteries, leading to various functional and structural changes. Systolic hypertension is a common occurrence in human ageing, and it is associated with large artery stiffening, heightened pulsatility, small artery remodeling, and damage to critical microvascular structures. Starting from young adulthood, a progressive elevation in the mean arterial pressure is evidenced by clinical and epidemiological data as well as findings from animal models. The myogenic response, a protective mechanism for the microcirculation, may face disruptions during ageing. The dysregulation of calcium entry channels (L-type, T-type, and TRP channels), dysfunction in intracellular calcium storage and extrusion mechanisms, altered expression of potassium channels, and a change in smooth muscle calcium sensitization may contribute to the age-related dysregulation of myogenic tone. Flow-mediated vasodilation, a hallmark of endothelial function, is compromised in ageing. This endothelial dysfunction is related to increased oxidative stress, lower nitric oxide bioavailability, and a low-grade inflammatory response, further exacerbating vascular dysfunction. Resistance artery remodeling in ageing emerges as a hypertrophic response of the vessel wall that is typically observed in conjunction with outward remodeling (in normotension), or as inward hypertrophic remodeling (in hypertension). The remodeling process involves oxidative stress, inflammation, reorganization of actin cytoskeletal components, and extracellular matrix fiber proteins. Reactive oxygen species (ROS) signaling and chronic low-grade inflammation play substantial roles in age-related vascular dysfunction. Due to its role in the regulation of vascular tone and structural proteins, the RhoA/Rho-kinase pathway is an important target in age-related vascular dysfunction and diseases. Understanding the intricate interplay of these factors is crucial for developing targeted interventions to mitigate the consequences of ageing on resistance arteries and enhance the overall vascular health.

Stiffness and Aging in Cardiovascular Diseases: The Dangerous Relationship between Force and Senescence

Paradigms of endothelial stiffening in cardiovascular disease and vascular aging

Vascular Stiffness in Aging and Disease

Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging.

Cells and extracellular matrix interplay in cardiac valve disease: because age matters

Mapping the unicellular transcriptome of the ascending thoracic aorta to changes in mechanosensing and mechanoadaptation during aging

Cellular Senescence: The Driving Force of Musculoskeletal Diseases

Vascular aging, the vascular cytoskeleton and aortic stiffness

Functional, Structural and Proteomic Effects of Ageing in Resistance Arteries

The cellular mechanobiology of aging: from biology to mechanics

Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease

Vascular Aging and Disease of the Large Vessels: Role of Inflammation

Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging

Aging-Induced Biological Changes and Cardiovascular Diseases

Views from Within and Beyond: Narratives of Cardiac Contractile Dysfunction under Senescence.

Cardiovascular aging: from cellular and molecular changes to therapeutic interventions

The Senescent Heart—"Age Doth Wither Its Infinite Variety"

Views from within and beyond

Effect of Aging on Cellular Mechanotransduction

Aging impairs smooth muscle-mediated regulation of aortic stiffness: a defect in shock absorption function?

Extracellular Vesicles and Cardiac Aging